======= ANGEL2 ======= == Gene Information == * **Official Symbol**: ANGEL2 * **Official Name**: angel homolog 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=90806|90806]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5VTE6|Q5VTE6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANGEL2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANGEL2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/619001|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Exo endo phos| |3-UTR-mediated mRNA stabilization| |3-5-exoribonuclease activity| |RNA phosphodiester bond hydrolysis, exonucleolytic| |mRNA stabilization| |RNA stabilization| |Cajal body| |negative regulation of mRNA catabolic process| |negative regulation of RNA catabolic process| |mRNA 3-UTR binding| |negative regulation of mRNA metabolic process| |RNA phosphodiester bond hydrolysis| |regulation of mRNA stability| |regulation of RNA stability| |regulation of mRNA catabolic process| |negative regulation of cellular catabolic process| |nucleic acid phosphodiester bond hydrolysis| |negative regulation of mitotic cell cycle| |negative regulation of catabolic process| |regulation of mRNA metabolic process| |posttranscriptional regulation of gene expression| |negative regulation of cell cycle| |regulation of mitotic cell cycle| |regulation of cellular catabolic process| |regulation of catabolic process| |regulation of cell cycle| |negative regulation of RNA metabolic process| |negative regulation of nucleobase-containing compound metabolic process| |RNA metabolic process| |positive regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp189|Temozolomide 200μM R04 exp189]]|1.72| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|2.08| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|2.3| ^Gene^Correlation^ |[[:human genes:g:gtpbp10|GTPBP10]]|0.46| |[[:human genes:c:c12orf65|C12orf65]]|0.449| |[[:human genes:c:c17orf89|C17orf89]]|0.429| |[[:human genes:r:rnaseh1|RNASEH1]]|0.424| |[[:human genes:m:mrpl15|MRPL15]]|0.423| |[[:human genes:m:mrps5|MRPS5]]|0.415| |[[:human genes:c:cox6c|COX6C]]|0.409| |[[:human genes:w:wbscr16|WBSCR16]]|0.406| |[[:human genes:g:gfm1|GFM1]]|0.401| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9409 * **Expression level (log2 read counts)**: 5.9 {{:chemogenomics:nalm6 dist.png?nolink |}}